Results 31 to 40 of about 1,396,034 (289)

Venous thromboembolism in patients with adrenocortical carcinoma after surgery

Endocrine Connections, 2020
Background: Adrenocortical carcinoma is a rare malignancy with a poor prognosis. We hypothesized that patients with adrenocortical carcinoma are at high risk for venous thromboembolism, given the numerous risk factors such as malignancy, abdominal ...
Jülide Durmuşoğlu, Henri J L M Timmers, Pepijn van Houten, Hans F Langenhuijsen, Ad R M M Hermus, Annenienke C van de Ven   +5 more
doaj   +1 more source

Case Report: Surgery to remove adrenocortical oncocytic carcinoma from an Asian male

Frontiers in Surgery, 2023
Adrenocortical oncocytic carcinoma is a rare type of adrenocortical tumor. Its clinical characteristics and biological behavior need to be further evaluated after the accumulation of cases.
Hongtao Liu, Kai Huang, Dan Liu, Yehua Wang   +3 more
doaj   +1 more source

Adrenocortical Carcinoma

Cancer, 2000
Angelousi A, Kassi E, Kaltsas GA.
europepmc   +2 more sources

Embolization in an adrenocortical carcinoma as palliative therapy [PDF]

, 1999
Background: With an annual incidence of 0.2% of new cases per 100,000 inhabitants, adrenocortical carcinoma is rare. In advanced tumor only palliative treatment modalities are practicable. Because of scarcity of the tumor, standard treatment has not been
Braunschweig, R., Forstpointner, Roswitha, Kühl, M., Lang, N., Meissner, H., Schalhorn, Andreas   +5 more
core   +1 more source

Pediatric adrenocortical carcinoma revealed by isolated Cushing syndrome: A case report

Journal of Pediatric Surgery Case Reports, 2023
Background: Adrenocortical carcinoma accounts for less than 0.2% of all pediatric malignancies. Virilization is the most common revealing sign, whereas hyperaldosteronism and Cushing syndrome are less common.We report a case of adrenocortical carcinoma ...
Hakima Chafaaoui, Assan Beaudelaire Romulus, Saad Andaloussi, Omar Dalero, Aziz Elmadi   +4 more
doaj   +1 more source

European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors.

European Journal of Endocrinology, 2018
Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of ...
M. Fassnacht, O. Dekkers, T. Else, E. Baudin, A. Berruti, R. D. de Krijger, H. Haak, R. Mihai, G. Assié, M. Terzolo   +9 more
semanticscholar   +1 more source

Giant nonfunctioning adrenal tumors: two case reports and review of the literature

Journal of Medical Case Reports, 2018
Background There are an estimated 1–2 cases per million per year of adrenocortical carcinoma in the USA. It represents a rare and aggressive malignancy; it is the second most aggressive endocrine malignant disease after anaplastic thyroid carcinoma.
George Chatzoulis, Ioannis Passos, Dimitra-Rafailia Bakaloudi, Dimitrios Giannakidis, Alexandros Koumpoulas, Konstantinos Ioannidis, Ioannis Tsifountoudis, Dimitrios Pappas, Panagiotis Spyridopoulos   +8 more
doaj   +1 more source

Methylation status of Vitamin D receptor gene promoter in benign and malignant adrenal tumors [PDF]

, 2015
We previously showed a decreased expression of vitamin D receptor (VDR) mRNA/protein in a small group of adrenocortical carcinoma (ACC) tissues, suggesting the loss of a protective role of VDR against malignant cell growth in this cancer type ...
Cappellesso, Rocco, Fallo, Francesco, Fassina, Ambrogio, Guzzardo, Vincenza, Pilon, Catia, Rebellato, Andrea, Sasano, Hironobu, Urbanet, Riccardo   +7 more
core   +4 more sources

PD-1 Blockade in Advanced Adrenocortical Carcinoma.

Journal of Clinical Oncology, 2020
PURPOSE Adrenocortical carcinomas (ACC) are rare and aggressive malignancies with limited treatment options. This study was undertaken to evaluate the immunogenicity of ACC.
N. Raj, Youyun Zheng, V. Kelly, S. Katz, J. Chou, R. Do, M. Capanu, D. Zamarin, L. Saltz, C. Ariyan, B. Untch, E. O’Reilly, A. Gopalan, M. Berger, K. Olino, N. Segal, D. Reidy‐Lagunes   +16 more
semanticscholar   +1 more source

Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma

Journal for ImmunoTherapy of Cancer, 2020
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in ~60% of patients and associated with particularly poor prognosis.
Laura-Sophie Landwehr, B. Altieri, J. Schreiner, Iuliu Sbiera, I. Weigand, M. Kroiss, M. Fassnacht, S. Sbiera   +7 more
semanticscholar   +1 more source